Tag: Parkinson’s disease
Pesticide Chlorpyrifos Linked to More Than Double Risk of Parkinson’s Disease, UCLA Study Finds
Researchers at UCLA have found that long-term exposure to the pesticide chlorpyrifos approximately doubles the risk of Parkinson's disease, with…
How Brain-Spine Circuits Control Walking—And Why They Fail First in Aging and Parkinson’s Disease
Walking relies on integrated brain-spine circuits controlling posture, balance, and rhythm. New evidence shows aging and Parkinson's disease preferentially damage…
Adaptive Deep Brain Stimulation Restores Walking in Parkinson’s Disease: Nature Medicine Study
A new study in Nature Medicine demonstrates that deep brain stimulation devices using real-time neural decoding algorithms can significantly improve…
First Dual-Target Gene Therapy for Parkinson’s Disease Shows Promise in Early Trial
First-in-human trial of BBM-P002 dual-target gene therapy shows sustained 12-month motor improvements in Parkinson's disease patients with excellent safety profile.…
Orthostatic Hypotension in Parkinson’s Disease: New Clinical Practice Guidelines
New clinical guidelines address orthostatic hypotension, which affects up to 70% of Parkinson's patients. Evidence-based recommendations emphasize systematic screening and…
Gut microbiome screening could predict Parkinson’s disease risk years before symptoms emerge
New research published in Nature Medicine reveals that gut microbiome analysis could identify Parkinson's disease risk years before symptoms appear.…
Blocking Key Protein GPNMB Shows Promise in Halting Parkinson’s Disease Spread
Scientists have identified GPNMB, a protein that helps Parkinson's disease spread through the brain by creating a destructive cycle between…
Multi-arm platform trials could revolutionize neurological disease research
Platform trials could test 15-20 neurological treatments per decade compared to 3-5 using traditional methods. New Lancet commentary argues this…